Detalhe da pesquisa
1.
The potential role of stimulants in treating eating disorders.
Int J Eat Disord
; 55(3): 318-331, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846763
2.
Understanding the effects of reductionist biological views of eating disorder etiology on patient attitudes and behavior.
Int J Eat Disord
; 54(4): 488-491, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393156
3.
The costs and benefits of intensive day treatment programs and outpatient treatments for eating disorders: An idea worth researching.
Int J Eat Disord
; 54(7): 1099-1105, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825216
4.
A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa.
Int J Eat Disord
; 54(5): 872-878, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534199
6.
Le trouble de l'accès hyperphagique: Aperçu actualisé à l'intention des professionnels des soins primaires.
Can Fam Physician
; 68(6): 422-428, 2022 06.
Artigo
em Francês
| MEDLINE | ID: mdl-35701211
7.
Examining the association between deficits in self-concept clarity and eating disorder severity.
Eat Behav
; 51: 101810, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37690171
8.
Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa.
J Eat Disord
; 11(1): 81, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218020
9.
Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa.
J Eat Disord
; 11(1): 205, 2023 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974240